Handok Inc (002390)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Handok Inc (002390) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014381
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Handok Inc (Handok), formerly known as Handok Pharmaceuticals Co Ltd, is a pharmaceutical and health care company which develops, manufactures and distributes healthcare solutions. The company develops and provides pharmaceutical products including prescription drugs, OTC drugs, medical devices and in vitro diagnostics. The company’s products portfolio include amaryl and amaryl M, teveten, tritace, xatral XL, festal nicostop and clearteen. Handok offers prescription medicines for the treatment of diabetes, harmone dificiency, hemophilia, high blood pressure, skin ailments, ulcers, cancer, allergy and others. It supplies healthcare products for digestion, calcium, antibiotic pills and injections, skin ointment, diuretics, and anti-histamines. The company works in partnership with pharmaceutical companies for manufacturing and quality control across Asia. Handok is headquartered in Seoul, South Korea.

Handok Inc (002390) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Handok Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Handok Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Handok Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Handok Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Handok Inc, Medical Devices Deals, 2011 to YTD 2017 10
Handok Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Handok Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Handok Enters into Agreement with Actelion Pharmaceuticals 12
Handok Enters into Agreement with Korea Roche 13
Handok Pharma Enters Into Co-Marketing Agreement With Novartis Korea For Onbrez Breezhaler 14
Handok Pharma Enters Into Co-Marketing Agreement With Nutricia For Nine Medical Nutrition Products 15
Teva Pharma To Form Joint Venture With Handok Pharma 16
Handok Enters Into Co-Marketing Agreement With Roche For Madopar 17
Taejoon Pharm Enters Into Co-Promotion Agreement With Handok Pharma For Gatiflo 18
HANDOK Enters Into Memorandum Of Understanding With Chonbuk National University Hospital 19
Handok and Genexine Enter into Co-Development Agreement 20
Handok Pharma Enters Into Co-Marketing Agreement With Fresenius Kabi 21
Licensing Agreements 22
Handok Pharma Enters Into Licensing Agreement With Mitsubishi Tanabe pharma 22
Debt Offering 23
Handok Raises USD26.4 Million in Public Offering of Bonds 23
Acquisition 24
Handok Acquires Theravalues from San-Eigen for USD18.4 Million 24
Handok Inc – Key Competitors 25
Handok Inc – Key Employees 26
Handok Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Handok Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Handok Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Handok Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Handok Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Handok Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Handok Inc, Medical Devices Deals, 2011 to YTD 2017 10
Handok Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Handok Enters into Agreement with Actelion Pharmaceuticals 12
Handok Enters into Agreement with Korea Roche 13
Handok Pharma Enters Into Co-Marketing Agreement With Novartis Korea For Onbrez Breezhaler 14
Handok Pharma Enters Into Co-Marketing Agreement With Nutricia For Nine Medical Nutrition Products 15
Teva Pharma To Form Joint Venture With Handok Pharma 16
Handok Enters Into Co-Marketing Agreement With Roche For Madopar 17
Taejoon Pharm Enters Into Co-Promotion Agreement With Handok Pharma For Gatiflo 18
HANDOK Enters Into Memorandum Of Understanding With Chonbuk National University Hospital 19
Handok and Genexine Enter into Co-Development Agreement 20
Handok Pharma Enters Into Co-Marketing Agreement With Fresenius Kabi 21
Handok Pharma Enters Into Licensing Agreement With Mitsubishi Tanabe pharma 22
Handok Raises USD26.4 Million in Public Offering of Bonds 23
Handok Acquires Theravalues from San-Eigen for USD18.4 Million 24
Handok Inc, Key Competitors 25
Handok Inc, Key Employees 26
Handok Inc, Other Locations 27
Handok Inc, Subsidiaries 27

★海外企業調査レポート[Handok Inc (002390)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Norfolk Southern Corp (NSC):企業の財務・戦略的SWOT分析
    Norfolk Southern Corp (NSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Grupo Bimbo S.A. de C.V.:企業の戦略・SWOT・財務情報
    Grupo Bimbo S.A. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Bimbo S.A. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Holder Construction Co:企業の戦略的SWOT分析
    Holder Construction Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Molinos Rio de la Plata SA (MOLI3):企業の財務・戦略的SWOT分析
    Molinos Rio de la Plata SA (MOLI3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • MTAA Superannuation Fund:企業の戦略的SWOT分析
    MTAA Superannuation Fund - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Charter Communications Inc (CHTR):企業の財務・戦略的SWOT分析
    Charter Communications Inc (CHTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773):製薬・医療:M&Aディール及び事業提携情報
    Summary Chengdu Kanghong Pharmaceuticals Group Co Ltd (Chengdu Kanghong Pharmaceuticals) is a pharmaceutical company that develops, manufactures and markets Chinese medicines, chemical drugs and biological products. The company offers products for the treatment of medical conditions related to centr …
  • Calfrac Well Services Ltd (CFW):企業の財務・戦略的SWOT分析
    Calfrac Well Services Ltd (CFW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • EchoStar Corporation:企業の戦略・SWOT・財務情報
    EchoStar Corporation - Strategy, SWOT and Corporate Finance Report Summary EchoStar Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tenaga Nasional Berhad:戦略・SWOT・企業財務分析
    Tenaga Nasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Tenaga Nasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Conair Corporation
    Conair Corporation - Strategy, SWOT and Corporate Finance Report Summary Conair Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Crowley Maritime Corporation:石油・ガス:M&Aディール及び事業提携情報
    Summary Crowley Maritime Corp (Crowley Maritime) is a transportation and logistics company that offers marine solutions and services. Its service portfolio includes shipping and logistics, Alaska fuel sales and distribution, petroleum and chemical transportation, harbor ship assist and tanker escort …
  • TreeHouse Foods, Inc.:企業のM&A・事業提携・投資動向
    TreeHouse Foods, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TreeHouse Foods, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Chembio Diagnostic Inc (CEMI):医療機器:M&Aディール及び事業提携情報
    Summary Chembio Diagnostic Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP). Its DPP technol …
  • bebe stores, inc.:企業の戦略・SWOT・財務分析
    bebe stores, inc. - Strategy, SWOT and Corporate Finance Report Summary bebe stores, inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ribomic Inc (4591):製薬・医療:M&Aディール及び事業提携情報
    Summary Ribomic Inc (Ribomic), a subsidiary of Otsuka Pharmaceutical Co Ltd, is a biopharmaceutical venture company. The company develops molecular targeted pharmaceutical drugs using RNA aptamers. Its technology includes RiboART system a platform technology to treat therapeutic aptamers. Ribomic’s …
  • G. Siempelkamp GmbH & Co KG:企業の戦略的SWOT分析
    G. Siempelkamp GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Duke Energy Carolinas LLC:企業の戦略的SWOT分析
    Duke Energy Carolinas LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Powerco Ltd:発電所・企業SWOT分析
    Powerco Ltd – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Dabur India Ltd (DABUR):企業の財務・戦略的SWOT分析
    Dabur India Ltd (DABUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆